Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here
Because of our late phase and post-marketing expertise, we have the capabilities and services needed to fully support your needs. We provide the following late phase and post-marketing services:
Our therapeutic Centers of Excellence (COEs) support your late phase and post-marketing study by providing ecosystems of therapeutically aligned, cross-functional teams. These teams of experts help to enhance and underscore our capabilities and service offerings by creating synergies and efficiencies that help your study reach its goals and milestones. Our COEs cover the following specialty research areas:
Our dedicated team of cancer researchers creates solutions and provides consultations focused on the needs of your sites and patients — all while helping to save your study time and money.
Our infectious disease and vaccine site networks are dedicated to supporting this critical area of research in every area from immunizations to immunotherapy.
With more than 100 rare disease clinical trials completed, we provide the expertise and experience to meet the unique challenges of these studies.
We understand that allergy clinical trials and asthma clinical studies require present a variety of unique challenges that our Allergy CRO team is well-equipped to handle.
Pharm-Olam has the expertise, investigator relationships, and supportive technology to effectively deliver autoimmune clinical research studies.
Our U.S.-based team has worked for more than 30 years within the post-marketing and medical information area. Our impeccable record of service includes multiple successful FDA audits with zero findings in support of post-marketing and medical information activities.
Some of our services include:
For a full-list of our services in support of your post-marketing safety requirements, please see our Pharmacovigilance and Medical Information page.